| Literature DB >> 34806991 |
Elisabeth Rb Becker1, Ross Shegog1, Lara S Savas1, Erica L Frost1, C Mary Healy2, Stanley W Spinner3, Sally W Vernon1.
Abstract
BACKGROUND: Human papillomavirus (HPV) is a common and preventable sexually transmitted infection; however, vaccination rates in the United States among the target age group, which is 11-12 years, are lower than national goals. Interventions that address the barriers to and facilitators of vaccination are important for improving HPV vaccination rates. Web-based, text-based focus groups are becoming a promising method that may be well suited for conducting formative research to inform the design of digital behavior change intervention (DBCI) content and features that address HPV vaccination decision-making.Entities:
Keywords: focus groups; human papillomavirus; qualitative; sexually transmitted infection; vaccination
Year: 2021 PMID: 34806991 PMCID: PMC8663705 DOI: 10.2196/28846
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Parent demographics (N=22).
| Characteristic | Study participants | ||
|
| |||
|
| Value, mean (SD) | 41.95 (6.12) | |
|
| Value, range | 30-52 | |
|
| |||
|
| Value, mean (SD) | 1.95 (1.31) | |
|
| Value, median (range) | 2 (1-5) | |
|
| Value, mode | 1 | |
|
| Total male | 19 | |
|
| Total female | 24 | |
|
| |||
|
| Male | 1 (5) | |
|
| Female | 21 (95) | |
|
| |||
|
| White and non-Hispanic | 13 (59) | |
|
| Black or African American and non-Hispanic | 7 (32) | |
|
| Hispanicb | 2 (9) | |
|
| |||
|
| High school graduate | 4 (18) | |
|
| College graduate | 8 (36) | |
|
| Graduate or professional degree | 10 (45) | |
|
| |||
|
| Private health insurance | 18 (82) | |
|
| Medicaid | 2 (9) | |
|
| State Children’s Insurance Program | 1 (5) | |
|
| Military health care | 1 (5) | |
|
| |||
|
| Very hesitant | 2 (9) | |
|
| Hesitant | 1 (5) | |
|
| Unsure | 0 (0) | |
|
| Somewhat hesitant | 8 (36) | |
|
| Not hesitant | 11 (50) | |
|
| |||
|
|
| ||
|
|
| Yes | 0 (0) |
|
|
| No | 5 (100) |
|
|
| ||
|
|
| Yes | 14 (56) |
|
|
| No | 11 (44) |
|
| ≥ | ||
|
|
| Yes | 10 (77) |
|
|
| No | 3 (23) |
|
| |||
|
| Aware of Skype but never used it | 3 (14) | |
|
| Use sometimes | 18 (82) | |
|
| Use regularly | 1 (5) | |
|
| |||
|
| Skype chat (text-based only) | 8 (47) | |
|
| Skype call (audio and visual) | 1 (6) | |
|
| No preference | 8 (47) | |
aChildren aged 9-23 years.
bA total of 2 parents only reported Hispanic ethnicity and no racial category.
cIncludes human papillomavirus, Tdap (tetanus, diphtheria, and pertussis), meningitis, and influenza vaccination.
dHPV: human papillomavirus.
en=43 children; received at least one human papillomavirus vaccine dose.
fData missing for 5 parents.
Digital behavior change intervention (DBCI) content and feature design recommendations.
| Recommendation | Description | Quote numberb |
| Address HPVa knowledge barriers | Address prominent HPV and HPV vaccine knowledge barriers (ie, child being too young or sexually inexperienced, boys not being eligible, safety and side effects, and effectiveness) | 1, 2, 3, and 4 |
| Use trusted sources to educate and correct misinformation | Use pediatricians to communicate information as they are trusted and respected sources for children’s health | 17 and 18 |
| Focus on HPV messaging that resonates with parents | Frame HPV information in a way that resonates with parents (ie, preventing cancer) | 10, 11, 12, 13, and 14 |
| Guide parents on navigating reputable HPV resources | Provide reputable HPV resources to parents and guide them in using best practices for navigating consumer health information on the internet | 3, 4, 6, 7, 8, and 9 |
| Describe reputable HPV research in a comprehensible format | Interpret and describe HPV scientific research in a comprehensible format (ie, plain language at sixth-grade level and infographics) | 28 |
| Communicate who is sponsoring the DBCI | Communicate that trusted sources (ie, pediatric clinic network) are sponsoring the product | 5 |
| Design for self-tailoring | Design for the spectrum of parent information needs from reviews of basic information to reviews of scientific studies | 27 and 28 |
| Design for a family audience | Design for engagement between family members, including adolescents who may influence their parent’s decision-making | 19 and 20 |
| Design for reflection | Give parents the opportunity to reflect on the health experiences of others in their personal and extended networks to increase salience and relevancy | 15 and 16 |
| Organize and prepare for the clinic visit | Prepare parents for their child’s clinic visit by having them organize their questions and concerns beforehand | 21, 22, 23, and 24 |
| Extend the clinic visit and enhance the clinic network | Create infrastructure that extends the clinic visit and leverages the clinic network so parents can better connect with others and needed information before and after the clinic visit | 21, 22, 23, 24, 25, and 26 |
aHPV: human papillomavirus.
bThe numbers refer to the numbered quotations in the paper.
Skype feasibility and logistics.
| Category and description | Findings and experience | Reflections | ||||||
|
|
| Strength | Weakness | |||||
|
| ||||||||
|
|
Participants were asked about their previous experience using Skype and were given the option to choose between a Skype chat–based focus group and a Skype audiovisual–based focus group. |
Most participants had experience with using Skype before their session. Participants preferred a chat-based format over an audiovisual format. The original study plan to have half the sessions be audiovisual and half be text-only for comparative reasons was abandoned when scheduling for the large percentage of participants that requested a text-based format became prohibitive. |
The automatic transcripts produced from the text-based format allowed for immediate qualitative data analysis supporting rapid formative research. |
Insights from facial expression, physical gesturing, and prosody were difficult to discern and gather with the text-based format. | ||||
|
| ||||||||
|
|
Participants were instructed to log into their Skype study accounts 48 hours before their session and answer the welcome message. Participants were instructed to log-in a few minutes before their specified session and reply to the moderator’s welcome instructions. |
All participants successfully responded to the welcome message. On the day of the session, all participants successfully responded to the welcome instructions and attended their specified session. Most attended on time. |
Participants were able to navigate the Skype chat function without issue. Attendance was high, possibly because of familiarity with the Skype platform and the ease of participating from a preferred location. |
It was difficult to verify the identities of participants. | ||||
|
| ||||||||
|
|
Skype usernames (parents’ first name and ID number) and passwords were created for each participant and deleted at the conclusion of each session. |
By only using the participants’ first names, they were able to recognize when someone was addressing them but still keep their identity anonymous. |
Sensitive experiences were shared candidly. |
It was difficult to verify the identities of participants. | ||||
|
| ||||||||
|
|
A total of 4 team members ran each session: the lead moderator, a tech facilitator, and 2 submoderators. |
At times, the session moved very quickly, with participants answering questions simultaneously. Skype chat provided text bubbles when a participant was typing which aided the research team in establishing the cadence of asking questions. Preparing potential probes that could be easily modified and copy-pasted into the Skype chat proved advantageous for keeping pace with participants. Having participants use Skype on a laptop or desktop with a connected keyboard rather than on their phone proved advantageous for more uniform and rapid response time. |
All participants were able to contribute to all relevant questions at their own speed. |
The type-based format took more team members to moderate than an in-person session because of the high demands of processing incoming information spurred by simultaneous typing and posting. | ||||
|
| ||||||||
|
|
Unexpected outcomes occurred from the synchronous web-based format. |
Participants shared HPVa articles and video clips that influenced their decision to vaccinate in real time. At the conclusion of the focus groups, the team sent an email to all participants clarifying HPV misinformation, answering any HPV questions they posed during the focus groups and directing them to reputable sources. |
It was beneficial for the research team to see examples of actual content that influenced participants’ decision to vaccinate. The format increased the utility of participants to succinctly exemplify media, enabling more efficient understanding by the study team. |
It was important to clarify misinformation after the sessions as participants shared articles that used persuasive tactics of expert opinion and pseudoscience to discredit the HPV vaccine. | ||||
|
| ||||||||
|
|
A ‘how to download and use Skype’ guide with screenshots was distributed before the sessions. A technology facilitator was available during the sessions for support. |
No assistance was needed downloading or operating Skype. Two brief accidental calls occurred during one session but did not cause major disruption or require intervention. Technology support was not actively needed during the sessions. |
Participant familiarity and experience with Skype supported efficient operations. |
Although not needed, it may have proved difficult to help participants navigate technical challenges remotely. | ||||
|
| ||||||||
|
|
The costs of conducting the focus groups web-based versus in person were compared. |
Cost savings were estimated at US $260 for each session, accounting for transcription, parking reimbursements, and clinic staff after-hours pay. |
Skype is a free platform and provides cost savings compared with in-person methods. |
The format may bias participation toward those with access to a computer and internet and who feel comfortable with web-based communication. | ||||
aHPV: human papillomavirus.